Abstract Content

Abstracts should comprise the elements below, each beginning a new paragraph. Please refer to the sample Abstract at the end of this document.

Abstract Title. It should be a brief descriptive title (maximum of 20 words) in initial capital/lower case. Trademarks are not permitted.

Authors. Authors’ names should be supplied in the surname-last format and should be in initial capital/lower case. Institutional affiliations should be indicated with superscript numbers following the author name.

Affiliation(s). It should contain institution, State and Country.

Abstract Text. The text should not exceed 300 words and should be reduced to 250 words if an illustration is provided. If an abstract with an illustration is not reduced adequately, the Abstract Review Committee may decide to omit the illustration at their discretion.

Abstracts must be submitted as a Word document, in a text format. Abstracts submitted in a table format will be rejected.

Abstracts should be written in English and should be carefully proof read. The Abstract Review Committee reserves the right to correct abstracts for obvious spelling or grammatical errors without notice.

Abstract Sections

Abstracts should contain the following sections:

Background: Aims and objectives of the study, what the study covers, relevant background information and an outline of how the information will be presented.

Methods: Outline factually how the study was carried out and how the information was obtained.

Results: Present the results obtained from data gathering and the study as a whole. Results should be presented clearly, concisely and record only the facts. Relevant tables, graphs or pictorial evidence should be included in this section.

Abstracts reporting quantitative studies should contain the planned accrual target and the actual number of patients recruited, levels of significance and confidence intervals of results.

Conclusion: State or summarise the main points or findings of the study. This is where the aims of the study are revisited. No new information should be presented in this section.

References and acknowledgements: A limited number of key literature references may be added at the end of the abstract. The style of the references should follow the style of the Journal e.g. numbered or author/date style. Any references included in a reference list must be cited within the abstract text.

Mention source(s) of funding and any other acknowledgements briefly at the end of the abstract text.

References and acknowledgements are included in the 300 words count.


One small illustration per abstract is allowed. If an illustration is provided, the abstract word count is reduced to 250 words.

The illustration must be captioned, relevant to the abstract’s scientific content and cited in the text.

The illustration must be provided in a high resolution (publication standard) or the Abstract Review Committee may decide to omit the illustration at their discretion.

Oral Presentation and Poster Display

From the accepted abstracts a selection will be scheduled for an oral and a poster display or only a poster display.

Abstracts on completed studies and research outcomes may be given preference in selecting oral presentations, above all, over abstracts which do not report results but indicate that they will be reported at the meeting or contain descriptions of trial methodology.

Presenters selected for oral and poster presentations are expected to attend the 2018 ASM and cover their own costs of attendance.

Presenting Author Registration

The presenting author must be registered as a delegate at the MOGA ASM 2018 and will be required to cover their own costs to attend the meeting.

If the presenting author cannot attend the MOGA ASM 2018 an alternate can be considered. Alternate presenters need to be approved by the ASM Planning Committee. MOGA does not allow company representatives or staff to present abstracts on behalf of first authors.

Conflict of Interest & Author Contribution Forms

All authors must complete and return the Conflict of Interest and Author Contribution forms to the first author. The first author should email one signed copy of both forms and all forms completed by other authors to   

No Show Policy

Should a presenting author be absent without notice during the MOGA 2018 Meeting session the abstract is scheduled to be presented in, the presentation may be cancelled or presented by the Session Chair.


Trademarks may be used in the abstract text but only in brackets and only once, i.e. the first time the product/service is mentioned. The identity of drugs/technologies described in the abstract should be disclosed by means of generic name, a brief description or reference to a public source.


Submission of an abstract for the MOGA ASM 2018 implies the exclusive, unrestricted granting of copyright to MOGA to publish the abstract in the Abstract and Program Booklet, a supplement of the Asia-Pacific Journal of Clinical Oncology, and on the MOGA ASM 2018 Mobile App. Abstract authors retain full copyright.